Comparison of tumor-associated vasculatures in uveal and cutaneous melanomas

Seminars in Ophthalmology

Volumn 24, Issue 3, 2009, Pages 166-171

  Bhat, Pooja ^a   Jakobiec, Frederick A ^a   Folberg, Robert ^b  

^a MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

^b OAKLAND UNIVERSITY WILLIAM BEAUMONT SCHOOL OF MEDICINE   (United States)

Author keywords

Tumor microcirculation; Tumor associated vasculatures; Uveal melanoma microcirculation; Vasculogenic mimicry

Indexed keywords

ANGIOGENESIS; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; METASTASIS; MICROVASCULARIZATION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SKIN; TUMOR VASCULARIZATION; UVEA; UVEA MELANOMA; ANIMAL; COMPARATIVE STUDY; MELANOMA; MICROCIRCULATION; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PERIODIC ACID SCHIFF STAIN; SKIN TUMOR; UVEA TUMOR; VASCULARIZATION;

ANIMALS; HUMANS; MELANOMA; MICROCIRCULATION; NEOVASCULARIZATION, PATHOLOGIC; PERIODIC ACID-SCHIFF REACTION; PROGNOSIS; SKIN NEOPLASMS; UVEAL NEOPLASMS;

EID: 67651176033     PISSN: 08820538     EISSN: 17445205     Source Type: Journal    
DOI: 10.1080/08820530902805305     Document Type: Review

References (51)

1. Warren BA, Shubik P. The growth of the blood supply to melanoma transplants in the hamster cheek pouch. Lab Invest 1966;15(2):464-478.
2. Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med 1971;285(21):1182-1186.
3. Folkman J. What is the role of angiogenesis in metastasis from cutaneous melanoma? Eur J Cancer Clin Oncol 1987;23(4):361- 363.
4. Folkman J, Hanahan D. Switch to the angiogenic phenotype during tumorigenesis. Princess Takamatsu Symp 1991;22:339- 347.
5. Le Querrec A, Duval D, Tobelem G. Tumour angiogenesis. Baillieres Clin Haematol 1993;6(3):711-730.
6. Folberg R, Hendrix MJ, Maniotis AJ. Vasculogenic mimicry and tumor angiogenesis. Am J Pathol 2000;156(2):361-381.
7. Shields CL. The hunt for the secrets of uveal melanoma. Clin Experiment Ophthalmol 2008;36(3):277-280.
8. Sato T, Han F, Yamamoto A. The biology and management of uveal melanoma. Curr Oncol Rep 2008;10(5):431-438.
9. McLean IW, Saraiva VS, Burnier MN, Jr. Pathological and prognostic features of uveal melanomas. Can J Ophthalmol 2004;39(4):343-350.
10. McLean IW. The biology of haematogenous metastasis in human uveal malignant melanoma. Virchows Arch A Pathol Anat Histopathol 1993;422(6):433-437.
11. Folberg R, Pe'er J, Gruman LM, et al. The morphologic characteristics of tumor blood vessels as a marker of tumor progression in primary human uveal melanoma: a matched case-control study. Hum Pathol 1992;23(11):1298-1305.
12. Shields JA, Augsburger JJ, Brady LW, Day JL. Cobalt plaque therapy of posterior uveal melanomas. Ophthalmology 1982;89(10):1201-1207.
13. Gragoudas ES, Goitein M, Verhey L, et al. Proton beam irradiation. An alternative to enucleation for intraocular melanomas. Ophthalmology 1980;87(6):571-581.
14. Seregard S, Spangberg B, Juul C, Oskarsson M. Prognostic accuracy of the mean of the largest nucleoli, vascular patterns, and PC-10 in posterior uveal melanoma. Ophthalmology 1998;105(3):485-491.
15. Sakamoto T, Sakamoto M, Yoshikawa H, et al. Histologic findings and prognosis of uveal malignant melanoma in japanese patients. Am J Ophthalmol 1996;121(3):276-283.
16. McLean IW, Keefe KS, Burnier MN. Uveal melanoma. Comparison of the prognostic value of fibrovascular loops, mean of the ten largest nucleoli, cell type, and tumor size. Ophthalmology 1997;104(5):777-780.
17. Maniotis AJ, Folberg R, Hess A, et al. Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am J Pathol 1999;155(3):739-752.
18. Asahara T, Murohara T, Sullivan A, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997;275(5302):964-967.
19. Holash J, Maisonpierre PC, Compton D, et al. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. Science 1999;284(5422):1994-1998.
20. Mueller AJ, Bartsch DU, Folberg R, et al. Imaging the microvasculature of choroidal melanomas with confocal indocyanine green scanning laser ophthalmoscopy. Arch Ophthalmol 1998;116(1):31-39.
21. Maniotis AJ, Chen X, Garcia C, et al. Control of melanoma morphogenesis, endothelial survival, and perfusion by extracellular matrix. Lab Invest 2002;82(8):1031-1043.
22. Seftor RE, Seftor EA, Koshikawa N, et al. Cooperative interactions of laminin 5 gamma2 chain, matrix metalloproteinase-2, and membrane type-1-matrix/metalloproteinase are required for mimicry of embryonic vasculogenesis by aggressive melanoma. Cancer Res 2001;61(17):6322-6327.
23. Clarijs R, Otte-Holler I, Ruiter DJ, de Waal RM. Presence of a fluid-conducting meshwork in xenografted cutaneous and primary human uveal melanoma. Invest Ophthalmol Vis Sci 2002;43(4):912-918.
24. Lin AY, Maniotis AJ, Valyi-Nagy K, et al. Distinguishing fibrovascular septa from vasculogenic mimicry patterns. Arch Pathol Lab Med 2005;129(7):884-892.
25. Daniels KJ, Boldt HC, Martin JA, et al. Expression of type VI collagen in uveal melanoma: its role in pattern formation and tumor progression. Lab Invest 1996;75(1):55-66.
26. Smetsers TF, van de Westerlo EM, ten Dam GB, et al. Localization and characterization of melanoma-associated glycosaminoglycans: differential expression of chondroitin and heparan sulfate epitopes in melanoma. Cancer Res 2003;63(11):2965-2970.
27. Chen X, Ai Z, Rasmussen M, et al. Three-dimensional reconstruction of extravascular matrix patterns and blood vessels in human uveal melanoma tissue: techniques and preliminary findings. Invest Ophthalmol Vis Sci 2003;44(7):2834-2840.
28. Lin AY, Ai Z, Lee SC, et al. Comparing vasculogenic mimicry with endothelial cell-lined vessels: techniques for 3D reconstruction and quantitative analysis of tissue components from archival paraffin blocks. Appl Immunohistochem Mol Morphol 2007;15(1):113-119.
29. Makitie T, Summanen P, Tarkkanen A, Kivela T. Microvascular density in predicting survival of patients with choroidal and ciliary body melanoma. Invest Ophthalmol Vis Sci 1999;40(11):2471-2480.
30. Folberg R, Mehaffey M, Gardner LM, et al. The microcirculation of choroidal and ciliary body melanomas. Eye 1997;11 (Pt 2):227-238.
31. Folberg R, Maniotis AJ. Vasculogenic mimicry. Apmis 2004;112(7-8):508-525.
32. Frenkel S, Barzel I, Levy J, et al. Demonstrating circulation in vasculogenic mimicry patterns of uveal melanoma by confocal indocyanine green angiography. Eye 2008;22(7):948- 952.
33. Prescher G, Bornfeld N, Hirche H, et al. Prognostic implications of monosomy 3 in uveal melanoma. Lancet 1996;347(9010): 1222-1225.
34. Scholes AG, Damato BE, Nunn J, et al. Monosomy 3 in uveal melanoma: correlation with clinical and histologic predictors of survival. Invest Ophthalmol Vis Sci 2003;44(3):1008-1011.
35. Rummelt V, Mehaffey MG, Campbell RJ, et al. Microcirculation architecture of metastases from primary ciliary body and choroidal melanomas. Am J Ophthalmol 1998;126(2):303-305.
36. Kivela T, Makitie T, Al-Jamal RT, Toivonen P. Microvascular loops and networks in uveal melanoma. Can J Ophthalmol 2004;39(4):409-421.
37. Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics, 1999. CA Cancer J Clin 1999;49(1):8-31, 1.
38. Streit M, Detmar M. Angiogenesis, lymphangiogenesis, and melanoma metastasis. Oncogene 2003;22(20):3172-3179.
39. Barnhill RL, Mihm MC, Jr., Ceballos PI. Angiogenesis and regressing cutaneous malignant melanoma. Lancet 1992; 339(8799):991-992.
40. Wolf JE, Jr., Hubler WR, Jr. Tumor angiogenic factor and human skin tumors. Arch Dermatol 1975;111(3):321-327.
41. Hubler WR, Jr., Wolf JE, Jr. Melanoma. Tumor angiogenesis and human neoplasia. Cancer 1976;38(1):187-192.
42. Srivastava A, Laidler P, Hughes LE, et al. Neovascularization in human cutaneous melanoma: a quantitative morphological and Doppler ultrasound study. Eur J Cancer Clin Oncol 1986;22(10):1205-1209.
43. Dadras SS, Detmar M. Angiogenesis and lymphangiogenesis of skin cancers. Hematol Oncol Clin North Am 2004;18(5):1059- 1070, viii.
44. Srivastava A, Laidler P, Davies RP, et al. The prognostic significance of tumor vascularity in intermediate-thickness (0.76-4.0 mm thick) skin melanoma. A quantitative histologic study. Am J Pathol 1988;133(2):419-423.
45. Vlaykova T, Laurila P, Muhonen T, et al. Prognostic value of tumour vascularity in metastatic melanoma and association of blood vessel density with vascular endothelial growth factor expression. Melanoma Res 1999;9(1):59-68.
46. Kashani-Sabet M, Sagebiel RW, Ferreira CM, et al. Tumor vascularity in the prognostic assessment of primary cutaneous melanoma. J Clin Oncol 2002;20(7):1826-1831.
47. Carnochan P, Briggs JC, Westbury G, Davies AJ. The vascularity of cutaneous melanoma: a quantitative histological study of lesions 0.85-1.25 mm in thickness. Br J Cancer 1991;64(1): 102-107.
48. Busam KJ, Berwick M, Blessing K, et al. Tumor vascularity is not a prognostic factor for malignant melanoma of the skin. Am J Pathol 1995;147(4):1049-1056.
49. Nowak MA, Fatteh SM, Campbell TE. Glycogen-rich malignant melanomas and glycogen-rich balloon cell malignant melanomas: frequency and pattern of PAS positivity in primary and metastatic melanomas. Arch Pathol Lab Med 1998;122(4):353-360.
50. Sun BC, Zhang SW, Zhao XL, Hao XS. [Study on vasculogenic mimicry in malignant melanoma]. Zhonghua Bing Li Xue Za Zhi 2003;32(6):539-543.
51. Massi D, Franchi A, Paglierani M, et al. Vasculogenic mimicry has no prognostic significance in pT3 and pT4 cutaneous melanoma. Hum Pathol 2004;35(4):496-502.